Uncovering injury-specific proteomic signatures and neurodegenerative risks in single and repetitive traumatic brain injury

Abstract Traumatic brain injury (TBI) is a major public health concern associated with an increased risk of neurodegenerative diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD), and chronic traumatic encephalopathy, yet the underlying molecular mechanisms in repetitive TBI remain...

Full description

Saved in:
Bibliographic Details
Main Authors: Sarah Mantash, Soulaimane Aboulouard, Hassan Dakik, Yanis Zirem, Lydia Ziane-Chaouche, Ali Nehme, Khalil Mallah, Marya El-Kurdi, Naify Ramadan, Isabelle Fournier, Kazem Zibara, Firas Kobeissy, Michel Salzet
Format: Article
Language:English
Published: Nature Publishing Group 2025-06-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-025-02286-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849432674481995776
author Sarah Mantash
Soulaimane Aboulouard
Hassan Dakik
Yanis Zirem
Lydia Ziane-Chaouche
Ali Nehme
Khalil Mallah
Marya El-Kurdi
Naify Ramadan
Isabelle Fournier
Kazem Zibara
Firas Kobeissy
Michel Salzet
author_facet Sarah Mantash
Soulaimane Aboulouard
Hassan Dakik
Yanis Zirem
Lydia Ziane-Chaouche
Ali Nehme
Khalil Mallah
Marya El-Kurdi
Naify Ramadan
Isabelle Fournier
Kazem Zibara
Firas Kobeissy
Michel Salzet
author_sort Sarah Mantash
collection DOAJ
description Abstract Traumatic brain injury (TBI) is a major public health concern associated with an increased risk of neurodegenerative diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD), and chronic traumatic encephalopathy, yet the underlying molecular mechanisms in repetitive TBI remain poorly defined. This study investigates proteomic and behavioral changes following single and repetitive mild TBI in a mouse model, focusing on molecular alterations in the cortex and hippocampus across acute (48 h) and subacute (1 week) stages. Using shotgun proteomics and bioinformatics approaches, including weighted gene co-expression network analysis (WGCNA) and machine learning, we analyzed the proteomic landscapes of TBI-affected brain regions including the hippocampus and the cortex. We assessed motor and cognitive outcomes at 2-, 7-, and 30-days post-injury to explore functional impairments associated with observed molecular changes. Our findings reveal spatio-temporal injury- and time-specific proteomic changes, with a single TBI promoting neuroprotective and repair mechanisms, while repetitive TBI exacerbating neuronal damage and synaptic deficits in the hippocampus. Key deregulated proteins, including Apoa1, ApoE, Cox6a1, and Snca, were linked to neurodegenerative pathways, suggesting molecular connections between TBI and diseases like AD and PD. Behavioral assessments indicated that repetitive TBI significantly impaired motor and cognitive functions, with recovery in motor function by day 30, whereas cognitive deficits persisted. This study provides a detailed analysis of the proteomic and behavioral consequences of TBI, identifying molecular networks as potential biomarkers or therapeutic targets for mitigating long-term cognitive decline associated with repetitive head trauma. These findings underscore the importance of mitochondrial and synaptic integrity in TBI response and suggest that targeting these pathways could reduce neurodegenerative risk following repetitive TBI.
format Article
id doaj-art-a36fc2de539f47c4815b39ac4278bb5f
institution Kabale University
issn 2059-3635
language English
publishDate 2025-06-01
publisher Nature Publishing Group
record_format Article
series Signal Transduction and Targeted Therapy
spelling doaj-art-a36fc2de539f47c4815b39ac4278bb5f2025-08-20T03:27:18ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352025-06-0110112310.1038/s41392-025-02286-9Uncovering injury-specific proteomic signatures and neurodegenerative risks in single and repetitive traumatic brain injurySarah Mantash0Soulaimane Aboulouard1Hassan Dakik2Yanis Zirem3Lydia Ziane-Chaouche4Ali Nehme5Khalil Mallah6Marya El-Kurdi7Naify Ramadan8Isabelle Fournier9Kazem Zibara10Firas Kobeissy11Michel Salzet12Department of Experimental pathology, Immunology and Microbiology, Faculty of Medicine, American University of BeirutLaboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), Univ. Lille, Inserm, CHU Lille, U1192Research Institute of the McGill University Health CentreLaboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), Univ. Lille, Inserm, CHU Lille, U1192Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), Univ. Lille, Inserm, CHU Lille, U1192Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of BeirutDepartment of Pharmacology and Immunology, Medical University of South CarolinaDepartment of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of BeirutDepartment of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of BeirutLaboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), Univ. Lille, Inserm, CHU Lille, U1192Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of BeirutDepartment of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of BeirutLaboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), Univ. Lille, Inserm, CHU Lille, U1192Abstract Traumatic brain injury (TBI) is a major public health concern associated with an increased risk of neurodegenerative diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD), and chronic traumatic encephalopathy, yet the underlying molecular mechanisms in repetitive TBI remain poorly defined. This study investigates proteomic and behavioral changes following single and repetitive mild TBI in a mouse model, focusing on molecular alterations in the cortex and hippocampus across acute (48 h) and subacute (1 week) stages. Using shotgun proteomics and bioinformatics approaches, including weighted gene co-expression network analysis (WGCNA) and machine learning, we analyzed the proteomic landscapes of TBI-affected brain regions including the hippocampus and the cortex. We assessed motor and cognitive outcomes at 2-, 7-, and 30-days post-injury to explore functional impairments associated with observed molecular changes. Our findings reveal spatio-temporal injury- and time-specific proteomic changes, with a single TBI promoting neuroprotective and repair mechanisms, while repetitive TBI exacerbating neuronal damage and synaptic deficits in the hippocampus. Key deregulated proteins, including Apoa1, ApoE, Cox6a1, and Snca, were linked to neurodegenerative pathways, suggesting molecular connections between TBI and diseases like AD and PD. Behavioral assessments indicated that repetitive TBI significantly impaired motor and cognitive functions, with recovery in motor function by day 30, whereas cognitive deficits persisted. This study provides a detailed analysis of the proteomic and behavioral consequences of TBI, identifying molecular networks as potential biomarkers or therapeutic targets for mitigating long-term cognitive decline associated with repetitive head trauma. These findings underscore the importance of mitochondrial and synaptic integrity in TBI response and suggest that targeting these pathways could reduce neurodegenerative risk following repetitive TBI.https://doi.org/10.1038/s41392-025-02286-9
spellingShingle Sarah Mantash
Soulaimane Aboulouard
Hassan Dakik
Yanis Zirem
Lydia Ziane-Chaouche
Ali Nehme
Khalil Mallah
Marya El-Kurdi
Naify Ramadan
Isabelle Fournier
Kazem Zibara
Firas Kobeissy
Michel Salzet
Uncovering injury-specific proteomic signatures and neurodegenerative risks in single and repetitive traumatic brain injury
Signal Transduction and Targeted Therapy
title Uncovering injury-specific proteomic signatures and neurodegenerative risks in single and repetitive traumatic brain injury
title_full Uncovering injury-specific proteomic signatures and neurodegenerative risks in single and repetitive traumatic brain injury
title_fullStr Uncovering injury-specific proteomic signatures and neurodegenerative risks in single and repetitive traumatic brain injury
title_full_unstemmed Uncovering injury-specific proteomic signatures and neurodegenerative risks in single and repetitive traumatic brain injury
title_short Uncovering injury-specific proteomic signatures and neurodegenerative risks in single and repetitive traumatic brain injury
title_sort uncovering injury specific proteomic signatures and neurodegenerative risks in single and repetitive traumatic brain injury
url https://doi.org/10.1038/s41392-025-02286-9
work_keys_str_mv AT sarahmantash uncoveringinjuryspecificproteomicsignaturesandneurodegenerativerisksinsingleandrepetitivetraumaticbraininjury
AT soulaimaneaboulouard uncoveringinjuryspecificproteomicsignaturesandneurodegenerativerisksinsingleandrepetitivetraumaticbraininjury
AT hassandakik uncoveringinjuryspecificproteomicsignaturesandneurodegenerativerisksinsingleandrepetitivetraumaticbraininjury
AT yaniszirem uncoveringinjuryspecificproteomicsignaturesandneurodegenerativerisksinsingleandrepetitivetraumaticbraininjury
AT lydiazianechaouche uncoveringinjuryspecificproteomicsignaturesandneurodegenerativerisksinsingleandrepetitivetraumaticbraininjury
AT alinehme uncoveringinjuryspecificproteomicsignaturesandneurodegenerativerisksinsingleandrepetitivetraumaticbraininjury
AT khalilmallah uncoveringinjuryspecificproteomicsignaturesandneurodegenerativerisksinsingleandrepetitivetraumaticbraininjury
AT maryaelkurdi uncoveringinjuryspecificproteomicsignaturesandneurodegenerativerisksinsingleandrepetitivetraumaticbraininjury
AT naifyramadan uncoveringinjuryspecificproteomicsignaturesandneurodegenerativerisksinsingleandrepetitivetraumaticbraininjury
AT isabellefournier uncoveringinjuryspecificproteomicsignaturesandneurodegenerativerisksinsingleandrepetitivetraumaticbraininjury
AT kazemzibara uncoveringinjuryspecificproteomicsignaturesandneurodegenerativerisksinsingleandrepetitivetraumaticbraininjury
AT firaskobeissy uncoveringinjuryspecificproteomicsignaturesandneurodegenerativerisksinsingleandrepetitivetraumaticbraininjury
AT michelsalzet uncoveringinjuryspecificproteomicsignaturesandneurodegenerativerisksinsingleandrepetitivetraumaticbraininjury